Frazier Life Sciences Management, L.P. - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 190 filers reported holding KRYSTAL BIOTECH INC in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q2 2024$181,520,794
+3.2%
988,4600.0%8.49%
+14.4%
Q1 2024$175,876,688
+43.4%
988,4600.0%7.42%
+13.2%
Q4 2023$122,628,348
+6.9%
988,4600.0%6.56%
-13.9%
Q3 2023$114,661,360
-1.4%
988,460
-0.2%
7.62%
+9.7%
Q2 2023$116,256,524
+53.6%
990,260
+4.7%
6.94%
+26.7%
Q1 2023$75,689,284
-4.4%
945,407
-5.4%
5.48%
+11.3%
Q4 2022$79,199,165
+11.6%
999,737
-1.8%
4.92%
-9.9%
Q3 2022$70,982,000
-1.3%
1,018,388
-7.0%
5.47%
-19.5%
Q2 2022$71,924,000
+24.8%
1,095,407
+26.5%
6.79%
+38.2%
Q1 2022$57,640,000866,2504.91%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$38,530,0003.46%
S Squared Technology, LLC 80,215$3,453,0002.57%
First Light Asset Management, LLC 464,663$20,004,0002.05%
Redmile Group, LLC 1,501,945$64,659,0001.19%
Nicholas Investment Partners, LP 222,422$9,575,0001.04%
SPHERA FUNDS MANAGEMENT LTD. 184,573$7,946,0000.78%
HighMark Wealth Management LLC 18,894$813,0000.73%
Hood River Capital Management LLC 257,203$11,073,0000.48%
GARNET EQUITY CAPITAL HOLDINGS, INC. 40,000$1,722,0000.35%
Artal Group S.A. 237,500$10,224,0000.25%
View complete list of KRYSTAL BIOTECH INC shareholders